Invectys
Invectys is clinical stage immuno-oncology company spun-out of the prestigious Pasteur Institute, Paris. Since 2010, Invectys has raised $42million in private funds to develop two innovative platforms of immuno-therapy products which target "universal" tumor antigens and thus applicable to a wide range of cancers. The company's products can be used alone or in combination with existing medications.
Last updated on